Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Yavuz KarabağMetin ÇağdaşIbrahim RencuzogullariSüleyman Karakoyunİnanç ArtaçDoğan İlişMahmut YesinÖznur Sadioğlu ÇağdaşBernas AltıntaşCengiz BurakHalil Ibrahim TanboğaPublished in: European journal of clinical investigation (2018)
No-reflow can be predicted by systemic inflammation markers including WBC count, NLR and CAR measured from the blood sample obtained on admission. CAR has a higher clinical value than CRP, albumin level, WBC count and NLR in NR prediction.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- peripheral blood
- emergency department
- coronary artery bypass
- left ventricular